TNXP - Tonix Pharmaceuticals Holding Corp. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company dedicated to the development of pharmaceutical products to address public health challenges. Its drug development program is focused on delivering treatment for PTSD.
IPO Date: June 1, 2012
Sector: Healthcare
Industry: Biotech
Market Cap: $129.49M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.28 | 5.30%
Avg Daily Range (30 D): $0.34 | 3.00%
Avg Daily Range (90 D): $0.37 | 3.26%
Institutional Daily Volume
Avg Daily Volume: 7.2M
Avg Daily Volume (30 D): .53M
Avg Daily Volume (90 D): .49M
Trade Size
Avg Trade Size (Sh.): 749
Avg Trade Size (Sh.) (30 D): 92
Avg Trade Size (Sh.) (90 D): 83
Institutional Trades
Total Institutional Trades: 333
Avg Institutional Trade: $1.58M
Avg Institutional Trade (30 D): $1.63M
Avg Institutional Trade (90 D): $1.61M
Avg Institutional Trade Volume: .04M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2M
Avg Closing Trade (30 D): $1.77M
Avg Closing Trade (90 D): $1.8M
Avg Closing Volume: 54.71K
 
News
Jun 8, 2026 @ 11:00 AM
Tonix Pharmaceuticals Secures Second Commercial Pa...
Source: Na
May 28, 2026 @ 6:00 PM
Bay Area Lyme Foundation Raises $900,000 at LymeAi...
Source: Bay Area Lyme Foundation
May 14, 2026 @ 11:00 AM
Tonix Pharmaceuticals to Present Retrospective U.S...
Source: Na
Apr 15, 2026 @ 11:00 AM
Tonix Pharmaceuticals Announces Publication of Ste...
Source: Tonix Pharmaceuticals
Mar 18, 2026 @ 8:58 PM
Tonix Pharmaceuticals to Present at BIO-Europe Spr...
Source: Na
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-13.06 $-2.44 $-2.93
Diluted EPS $-13.06 $-2.44 $-2.93
Revenue $29.1M $13.54M $6.88M
Gross Profit $24.4M $12.84M $5.3M
Net Income / Loss $-159.67M $-40.55M $-40.19M
Operating Income / Loss $-165.43M $-42.54M $-41.54M
Cost of Revenue $4.71M $.7M $1.58M
Net Cash Flow $50.38M $-9.39M $-23.8M
PE Ratio    
Splits
Feb 05, 2025 1:100
Jun 10, 2024 1:32
May 10, 2023 4:25
May 17, 2022 1:32
Nov 01, 2019 1:10
Nov 28, 2018 1:10
Mar 17, 2017 1:10
May 01, 2013 1:20